Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Irritable Bowel Syndrome

Free Subscription 22.07.2019 2 Aliment Pharmacol Ther 1 Ann Clin Lab Sci 1 Biomed Pharmacother 2 Clin Gastroenterol Hepatol 1 Clin Pharmacol Transl Med 1 Clin Transl Gastroenterol 1 Curr Opin Clin Nutr Metab Care 1 Eur J Clin Microbiol Infect Dis 1 Eur J Nutr 2 Gastroenterology 2 J Clin Gastroenterol 1 Lancet Gastroenterol Hepatol 1 Medicine (Baltimore) 1 Nat Commun 1 Neurogastroenterol Motil 2 Nutrients 1 Steroids

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Aliment Pharmacol Ther

1. WANG XJ, Camilleri M, Vanner S, Tuck C, et al
   Review article: biological mechanisms for symptom causation by individual FODMAP subgroups - the case for a more personalised approach to dietary restriction.
   Aliment Pharmacol Ther. 2019 Jul 15. doi: 10.1111/apt.15419.
   PubMed     Text format     Abstract available
   
   
2. CREED F
   Review article: the incidence and risk factors for irritable bowel syndrome in population-based studies.
   Aliment Pharmacol Ther. 2019 Jul 17. doi: 10.1111/apt.15396.
   PubMed     Text format     Abstract available
   
   

   
   Ann Clin Lab Sci

3. KIM SY, Seo YS, Lee ES, Kim KN, et al
   Total Bilirubin Is Associated with Small Intestinal Bacterial Overgrowth in Diarrhea Predominant Irritable Bowel Syndrome.
   Ann Clin Lab Sci. 2019;49:344-352.
   PubMed     Text format     Abstract available
   
   

   
   Biomed Pharmacother

4. HOU Q, Zhu S, Zhang C, Huang Y, et al
   Berberine improves intestinal epithelial tight junctions by upregulating A20 expression in IBS-D mice.
   Biomed Pharmacother. 2019;118:109206.
   PubMed     Text format     Abstract available
   
   

   
   Clin Gastroenterol Hepatol

5. MCNAUGHTON DT, Andreasson A, Ljotsson B, Beath AP, et al
   Effects of Psychology and Extra-Gastrointestinal Symptoms on Healthcare Use by Subjects With and Without Irritable Bowel Syndrome.
   Clin Gastroenterol Hepatol. 2019 Jul 16. pii: S1542-3565(19)30752.
   PubMed     Text format     Abstract available
   
   
6. BLACK CJ, Burr NE, Ford AC
   Relative Efficacy of Tegaserod in a Systematic Review and Network Meta-analysis of Licensed Therapies for Irritable Bowel Syndrome with Constipation.
   Clin Gastroenterol Hepatol. 2019 Jul 11. pii: S1542-3565(19)30740.
   PubMed     Text format    
   
   

   
   Clin Pharmacol Transl Med

7. GETACHEW B, Reyes RE, Davies DL, Tizabi Y, et al
   Moxidectin Effects on Gut Microbiota of Wistar-Kyoto Rats: Relevance to Depressive-Like Behavior.
   Clin Pharmacol Transl Med. 2019;3:134-142.
   PubMed     Text format     Abstract available
   
   

   
   Clin Transl Gastroenterol

8. WALDMAN SA, Tenenbaum R, Foehl HC, Winkle P, et al
   Blunted Evoked Prouroguanylin Endocrine Secretion in Chronic Constipation.
   Clin Transl Gastroenterol. 2019 Jul 17. doi: 10.14309/ctg.0000000000000016.
   PubMed     Text format     Abstract available
   
   

   
   Curr Opin Clin Nutr Metab Care

9. GUERREIRO M, Sousa Guerreiro C, Cravo M
   Irritable bowel syndrome: how can symptoms and quality of life be improved with diet?
   Curr Opin Clin Nutr Metab Care. 2019 Jul 10. doi: 10.1097/MCO.0000000000000589.
   PubMed     Text format     Abstract available
   
   

   
   Eur J Clin Microbiol Infect Dis

10. CARTER BL, Stiff RE, Elwin K, Hutchings HA, et al
    Health sequelae of human cryptosporidiosis-a 12-month prospective follow-up study.
    Eur J Clin Microbiol Infect Dis. 2019 Jul 14. pii: 10.1007/s10096-019-03603.
    PubMed     Text format     Abstract available
    
    

    
    Eur J Nutr

11. ABHARI K, Saadati S, Hosseini-Oskouiee F, Yari Z, et al
    Is Bacillus coagulans supplementation plus low FODMAP diet superior to low FODMAP diet in irritable bowel syndrome management?
    Eur J Nutr. 2019 Jul 20. pii: 10.1007/s00394-019-02060.
    PubMed     Text format     Abstract available
    
    

    
    Gastroenterology

12. SMALLEY W, Falck-Ytter C, Carrasco-Labra A, Wani S, et al
    American Gastroenterological Association Guideline on Mild-to-Moderate Ulcerative Colitis on the Laboratory Evaluation of Functional Diarrhea and Diarrhea-Predominant Irritable Bowel Syndrome in Adults (IBS-D).
    Gastroenterology. 2019 Jul 11. pii: S0016-5085(19)41083.
    PubMed     Text format    
    
    
13. 
    Irritable Bowel Syndrome in Adults (IBS-D): Clinical Decision Support Tool.
    Gastroenterology. 2019 Jul 16. pii: S0016-5085(19)41088.
    PubMed     Text format    
    
    

    
    J Clin Gastroenterol

14. BARAM MA, Abbasnezhad A, Ghanadi K, Anbari K, et al
    Serum Levels of Chemerin, Apelin, and Adiponectin in Relation to Clinical Symptoms, Quality of Life, and Psychological Factors in Irritable Bowel Syndrome.
    J Clin Gastroenterol. 2019 Jul 12. doi: 10.1097/MCG.0000000000001227.
    PubMed     Text format     Abstract available
    
    
15. SINGH P, Duehren S, Katon J, Rangan V, et al
    Breath Methane Does Not Correlate With Constipation Severity or Bloating in Patients With Constipation.
    J Clin Gastroenterol. 2019 Jul 12. doi: 10.1097/MCG.0000000000001239.
    PubMed     Text format     Abstract available
    
    

    
    Lancet Gastroenterol Hepatol

16. ARONIADIS OC, Brandt LJ, Oneto C, Feuerstadt P, et al
    Faecal microbiota transplantation for diarrhoea-predominant irritable bowel syndrome: a double-blind, randomised, placebo-controlled trial.
    Lancet Gastroenterol Hepatol. 2019 Jul 17. pii: S2468-1253(19)30198.
    PubMed     Text format     Abstract available
    
    

    
    Medicine (Baltimore)

17. ZHANG FM, Li S, Ding L, Xiang SH, et al
    Effectiveness of mesalazine to treat irritable bowel syndrome: A meta-analysis.
    Medicine (Baltimore). 2019;98:e16297.
    PubMed     Text format     Abstract available
    
    

    
    Nat Commun

18. BASAK S, Gicheru Y, Kapoor A, Mayer ML, et al
    Molecular mechanism of setron-mediated inhibition of full-length 5-HT3A receptor.
    Nat Commun. 2019;10:3225.
    PubMed     Text format     Abstract available
    
    

    
    Neurogastroenterol Motil

19. BUCKLEY MM, O'Brien R, Buckley JM, O'Malley D, et al
    GHSR-1 agonist sensitizes rat colonic intrinsic and extrinsic neurons to exendin-4: A role in the manifestation of postprandial gastrointestinal symptoms in irritable bowel syndrome?
    Neurogastroenterol Motil. 2019 Jul 16:e13684. doi: 10.1111/nmo.13684.
    PubMed     Text format     Abstract available
    
    

    
    Nutrients

20. DALE HF, Jensen C, Hausken T, Valeur J, et al
    Effects of a Cod Protein Hydrolysate Supplement on Symptoms, Gut Integrity Markers and Fecal Fermentation in Patients with Irritable Bowel Syndrome.
    Nutrients. 2019;11.
    PubMed     Text format     Abstract available
    
    
21. HILLS RD JR, Pontefract BA, Mishcon HR, Black CA, et al
    Gut Microbiome: Profound Implications for Diet and Disease.
    Nutrients. 2019;11.
    PubMed     Text format     Abstract available
    
    

    
    Steroids

22. OFFEI SD, Arman HD, Yoshimoto FK
    Chemical synthesis of 7alpha-hydroxycholest-4-en-3-one, a biomarker for irritable bowel syndrome and bile acid malabsorption.
    Steroids. 2019 Jul 11:108449. doi: 10.1016/j.steroids.2019.108449.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Irritable Bowel Syndrome is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: